BackBright Minds Biosciences Overview

Bright Minds Biosciences Total Assets

Track Bright Minds Biosciences's total assets ($310M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$312.15M
↑ 452.77% YoYΔ $255.68M vs prior year quarter

Peer trimmed avg / median

Loading

Bright Minds Biosciences Total Assets History

Loading

Bright Minds Biosciences vs. peers: Total Assets Comparison

Loading

Bright Minds Biosciences Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Bright Minds Biosciences (DRUG) FAQ

As of the most recent data (March 2026), DRUG shows a total assets of $310M. That compares with $56M in the prior-year period — up 452.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, DRUG's total assets is now $310M (was $56M) — a 452.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Bright Minds Biosciences is outperforming or lagging.

Tracking DRUG's total assets over time shows whether Bright Minds Biosciences is scaling, shrinking, or reshaping that part of the business. The current reading is $310M That compares with $56M in the prior-year period — up 452.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Bright Minds Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $310M) with ownership activity and broader fundamentals.

Bright Minds Biosciences's total assets is $310M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.